Fundraising

Cairn Therapeutics is raising funds to support our First in Human Phase I trial, which is scheduled to begin in Q3’26. We have completed all necessary preclinical studies and are finalizing our Drug Product, set for completion in Q2’26. With our IND submission planned  for Q3’26, your investment will be pivotal in advancing our groundbreaking cancer therapies.